|
TCRX
|
TScan Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TEVA
|
Teva Pharmaceutical Industries
|
US
|
NYSE
|
|
TGTX
|
TG Therapeutics, Inc.
|
US
|
NASDAQ
|
|
THRX
|
Theseus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TIL
|
Instil Bio, Inc.
|
US
|
NASDAQ
|
|
TLSA
|
Tiziana Life Sciences plc
|
US
|
NASDAQ
|
|
TMO
|
Thermo Fisher Scientific Inc
|
US
|
NYSE
|
|
TNGX
|
Tango Therapeutics
|
US
|
NASDAQ
|
|
TOVX
|
Theriva Biologics, Inc.
|
US
|
AMEX
|
|
TSVT
|
2seventy bio, Inc.
|
US
|
NASDAQ
|
|
TYRA
|
Tyra Biosciences, Inc.
|
US
|
NASDAQ
|
|
UNM
|
Unum Group
|
US
|
NYSE
|
|
UNMA
|
Unum Group 6.250% Junior Subordinated Notes due 2058
|
US
|
NYSE
|
|
URGN
|
UroGen Pharma Ltd.
|
US
|
NASDAQ
|
|
VACC
|
Vaccitech plc
|
US
|
NASDAQ
|
|
VBLT
|
Vascular Biogenics Ltd.
|
US
|
NASDAQ
|
|
VCNX
|
Vaccinex, Inc.
|
US
|
NASDAQ
|
|
VINC
|
Vincera Pharma, Inc.
|
US
|
NASDAQ
|
|
VIRX
|
Viracta Therapeutics, Inc.
|
US
|
NASDAQ
|
|
VKTX
|
Viking Therapeutics, Inc.
|
US
|
NASDAQ
|